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Abstract
Polysulfone (Psf) hollow fiber membranes (HFMs) have been widely used in blood purification but their biocompatibility
remains a concern. To enhance their biocompatibility, Psf/TPGS (d-a-tocopheryl polyethylene glycol 1000 succinate)
composite HFMs and 2-methacryloyloxyethyl phosphorylcholine (MPC) coated Psf HFMs have been prepared. They have
been evaluated for in vivo biocompatibility and graft acceptance and compared with sham and commercial membranes by
intra-peritoneal implantation in rats at day 7 and 21. Normal body weights, tissue formation and angiogenesis indicate
acceptance of implants by the animals. Hematological observations show presence of post-surgical stress which subsides
over time. Serum biochemistry results reveal normal organ function and elevated liver ALP levels at day 21. Histological
studies exhibit fibroblast recruitment cells, angiogenesis and collagen deposition at the implant surface indicating new
tissue formation. Immuno-histochemistry studies show non-activation of MHC molecules signifying biocompatibilty.
Additionally, Psf/TPGS exhibit most favorable tissue response as compared with other HFMs making them the material of
choice for HFM preparation for hemodialysis applications.
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Introduction
Membrane technology has proven vital in blood purification
applications, especially hemodialysis. In hollow fiber membranes
(HFMs), purification is achieved by regulating blood flow through
the lumen as the dialysate flows counter-currently outside. The
porous structure of the membrane facilitates diffusion of uremic
toxins like urea, creatinine etc. from blood to dialysate without the
loss of important blood proteins such as albumin. Desirable
characteristics of such HFMs include high flux, selectivity and
biocompatibility [1]. However, commercially available and most-
widely used polysulfone (Psf) hemodialysis membranes have
repeatedly been shown to be associated with clinical complications
like hypersensitivity reactions, neutropenia, oxidative stress,
contact and complement activation [2–5]. This translates into
decreased quality of life, life expectancy and mortality of
hemodialysis patients and has limited the success rates of such
membranes [6,7]. Thus, there is a need to enhance the
biocompatibility of such membranes without compromising flux
and selectivity.
Biocompatibility is the most desirable property of a biomaterial,
of being biologically compatible by not producing a toxic,
injurious and immunological response in living tissues or blood
for the case of extra-corporeal devices [8]. The most commonly
accepted mode of improving HFM biocompatibility has been
modification of surface chemistry. Ishihara et al. achieved
improved hemocompatibility of cellulose membranes under in
vitro conditions by grafting with 2–methacryloyloxyethyl phos-
phorylcholine (MPC) polymers [9]. Polyacrylonitrile dialysis
membranes, modified by covalent immobilization of chitosan/
heparin polyelectrolyte complexes, exhibited improved antithrom-
bogenicity and reduced platelet adhesion, thrombus formation and
protein adsorption [10]. In our earlier studies on NIH3T3 cells, we
showed that impregnation of d-a-tocopheryl polyethylene glycol
1000 succinate (TPGS) in Psf matrices enhances the biocompat-
ibility of native HFMs [11]. However, definitive in vivo studies are
required to assess the biocompatibility of such surface modified
HFMs before their practical application in hemodialysis.
During a typical hemodialysis procedure, blood is circulated at
200 ml/min through HFMs (surface areas ,1–2 m
2) for 3–5 h
thrice a week and such procedures lasts throughout the life of a
renal failure patient [12]. The continuous, long-term exposure of
blood to such membranes initiates various cellular reactions and
protein conformational changes, depending on the physico-
chemical nature of HFM surface. Hence, as per ISO 10993-1,
systemic toxicity evaluation of membrane material for a week is
necessary before hemodialysis trials [13]. These evaluations
require studies on circulating blood for which number of animal
models have been used [14]. Intra-peritoneal implantation in rats
is a proven method for systemic evaluations, since it exposes the
samples to both fluid and a variety of mesenchymal cell types of
abdominal cavity [15].
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biocompatibility of modified Psf/TPGS composite HFMs and
inner-surface coated MPC/Psf HFMs on Wistar rat model. The
effects of implanted membrane material on vital organ systems
such as liver, kidney etc. have been studied by hematology, serum
biochemistry and peritoneal fluid cytology. Tissue and immuno-
logical responses to HFMs have been evaluated using histopath-
ological observations and immuno-histochemistry. These studies
exhibit that Psf/TPGS membranes exhibit improved biocompat-
ibility as compared to the other studied membranes and are
suitable for practical hemodialysis applications.
Results and Discussion
Gross Observations
In any in vivo implant study the change in body weight is an
essential parameter to judge health of animal model. The basal
and final weights of rats at the time of implantation and after
exposure are shown in Table 1. After HFM exposure for 7 days,
the body weights of rats of normal, sham, Psf/TPGS and
Hemoflow F6 groups were increased by 20–30 gm and for Psf
and Psf/MPC groups, by 8–9 gm. By the 21st day, the increase in
body weight was 40–50 gm across all groups indicating healthy
condition of rats. Figure 1a and 2b are the camera images of Psf
HFMs implants in peritoneal cavity on day 7 and 21, respectively.
Both cases exhibit tissue formation on day 7 which becomes
distinct and accompanied by angiogenesis on day 21.
Blood Hematology and Serum Biochemistry Study
Blood hematology studies are carried out to determine surgery-
associated infections during implantation while serum biochemis-
try studies indicate functionalities of vital organs such as liver and
kidney. CBCs, differential leukocyte counts and serum protein
levels in blood of all groups after days 7 and 21 are listed in data
S1. CBCs across all groups were within the normal range [20]
after 7 and 21 days indicating that the implantation procedures
were devoid of any infections.
Slightly increased neutrophil numbers in Leukocyte differential
count on day 7 for Psf, Psf/TPGS, Psf/MPC and Hemoflow F6
groups indicated the presence of a mild inflammatory response as
compared to control and normal groups. These numbers subsided
and reached the normal level on the 21st day of implantation. This
is a usual phenomenon, which occurs in response to foreign
implants and is characterized by reduction in the inflammatory
response with increase in the implantation period [21].
In serum biochemistry measurements (data S1), liver enzymes
and serum proteins of all groups were within the normal range on
days 7 and 21. However, as compared to day 7, the ALT, AST,
and ALP enzyme concentrations for Psf, Psf/TPGS, Psf/MPC
and Hemoflow F6 groups were elevated on day 21 and were even
greater than the sham group. ALP has been documented as a
possible marker for wound healing [22] and may also indicate
tissue repair and angiogenesis. The observed ALP increase in
implanted groups only may, thus, be due to these processes. The
creatinine and blood urea nitrogen (BUN) values were within
normal ranges for all groups indicating healthy and functional
condition of kidney. Since all the implants are non-biodegradable
and non-leachable, so no malfunction of liver and kidney was
observed.
Peritoneal Fluid Cytology
Differential leukocyte counts performed on peritoneal fluid
collected on days 7 and 21 are listed in Table 2. As an initial
response to HFM implants, increased polymorphonucleocyte
(PMN) numbers were observed in the peritoneal fluid at day 7
when compared to the sham and normal groups. However at day
21, these numbers were within the normal range. The elevated
numbers may be due to the surgical procedure. Similar trends
were observed for neutrophils in differential leukocyte counts,
indicating the presence of post-surgical stress which subsides with
time. The decrease in this stress occurs because of wound healing
and tissue formation as the time progresses.
Tissue-HFM interaction study by Scanning Electron
Microscopy
SEM provides high resolution direct information on tissue-
biomaterial interactions with minimal sample preparation as
compared to histology. Further, histological sample preparation
causes implant detachment from tissues and this information is
preserved during SEM sample preparation. The SEM micro-
graphs of HFM implanted groups at day 21 are shown in Figure 2.
Dense tissue integration with the implant was observed in all the
cases (see inset micrographs). No masses were observed in the
implant bores or lumens. Degradation and material surface
changes due to body fluids were not observed. However, it is
difficult to extract detailed information about surrounding tissue/
cells type from these micrographs because of surface similarities in
different types of cells.
Histological Study of Implants
The optical microscopy based histological evaluation of tissues
surrounding the implant provides morphological and pathological
analysis. Tissue reactions in the implanted groups are summarized
in Table 3 and optical micrographs of respective histological
sections at day 7 and day 21 are shown in Figure 3. On day 7 post-
implantation, a relatively greater infiltration of polymorphonucle-
Table 1. Basal and final weight of normal, sham surgeries and implanted rats.
Day 7 (in gm) Day 21 (in gm)
Sample Type Basal Weight Final Weight Basal Weight Final Weight
Normal 150.00614.14 169.50630.60 170.50630.40 220.5063.53
Sham Surgeries 150.50616.26 180.0065.66 173.0062.83 220.0061.41
Psf 156.33616.77 165.33622.37 165.3362.08 213.00617.35
Psf/TPGS 165.67615.95 189.3368.33 154.3369.07 191.0069.90
Psf/MPC 164.00610.15 172.3360.58 159.67613.65 206.33617.62
Hemoflow F6 134.33622.55 165.33614.22 180.0068.00 227.0066.56
doi:10.1371/journal.pone.0025236.t001
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and Hemoflow F6 implants was observed as compared to the Psf
and Psf/TPGS implants. However, infiltration of fibroblasts
surrounding the implant and degrees of angiogenesis were more
prominent for Psf and Psf/TPGS implants than Psf/MPC and
Hemoflow F6 implants. On day 21, fibroblast recruitment was
enhanced, while angiogenesis remained the same for all cases as
compared to day 7. PMN, macrophage and lymphocyte
infiltrations were reduced on day 21 as compared to day 7.
Similar trends of reduction in PMNs, macrophages and lympho-
cytes with time upon implantation of disulfide-crosslinked
hyaluronan films have been reported earlier [23].
Collagen deposition is vital for new tissue formation and its
distribution and extent can be studied by Masson’s trichrome
staining. Figure 4 shows the optical micrographs of Masson’s
trichrome stained sections of different groups at days 7 and 21. On
day 7 post-implantation, thin collagen bundles (t) were observed
for all implants, while thick collagen bundles (T) were observed on
day 21. The increased collagen deposition may be due to increase
in fibroblast numbers (Table 3) which secrete collagen and is an
indicator of tissue formation. It has also been reported earlier for
poly(l-lactide-co-e-caprolactone) scaffolds implanted subcutaneou-
sely [24].
These histological studies exhibit favorable tissue response to all
implants indicating biocompatibility. However, the Psf/TPGS
group showed minimum lymphocytes and maximum fibroblasts
and angiogenesis (Table 3). These observations indicate that Psf/
TPGS achieves better tissue response as compared other HFM
implants, including commercial HFMs. This may be due to the
presence of TPGS, which leaches and cleaves into vitamin E and
polyethylene glycol moieties by enzymatic reactions [25]. Vitamin
E, a proven anti-oxidant [26], causes a reduction in implant-
associated oxidative stress and contributes to the better perfor-
mance of the Psf/TPGS implant.
Immunohistochemistry by Confocal Microscopy
Studies of immunological response of tissues with HFM
implants are vital for assessing host-verses-graft (implant) reactions.
HLA-DR is constitutively expressed on antigen-presenting im-
mune system cells like dendritic cells, B cells, and monocytes/
macrophages and its expression is further up-regulated upon
activation. It is, thus, considered as an essential marker for
activation of immune system [27,28]. The confocal micrographs of
normal peritoneal tissue and implanted groups stained with DAPI
for nuclei and phycoerythrin (PE) conjugated HLA- DR antibody
for MHC at day 21 are shown in Figure 5. The micrographs
Figure 1. Interaperitoneal implantation of HFM. Images of Psf implants in peritoneum during excision in CO2 euthanized rat at days 7 (a) and
days 27 (b).
doi:10.1371/journal.pone.0025236.g001
Table 2. Leukocyte differential counts for peritoneal fluid after HFM implantation.
Sample Type
Incubation Time
(days) PMN* Mononuclear** Lymphocytes Eosinophils Basophils
Normal (Without Surgery) 7 21626 1 661 6 631 601 60
Sham Surgeries 7 30615 1 621 5 621 601 60
Psf 7 42634 0 621 5 632 611 60
Psf/TPGS 7 39634 1 611 7 632 611 60
Psf/MPC 7 42644 1 641 4 602 611 60
Hemoflow F6 7 39634 3 641 5 622 611 60
Normal (Without Surgery) 21 19626 1 641 8 631 601 60
Sham Surgeries 21 20616 6 621 1 622 611 60
Psf 21 21626 1 651 5 622 601 60
Psf/TPGS 21 25625 7 641 6 632 610 60
Psf/MPC 21 24626 0 621 3 632 611 60
Hemoflow F6 21 19626 5 641 5 621 600 60
(*PMN=polymorph nucleocytes, i.e. granulocytes; **Mononuclear=monocytes, macrophages, and mesothelial).
doi:10.1371/journal.pone.0025236.t002
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fluorescence due to PE was not observed indicating non-activation
of immune cells in the tissues surrounding the implants. Also,
peritoneal fluid cytology showed normal leukocyte differential
count in implanted rats. This supports non-activation of immune
system at the implant site and indicates acceptance of the implants
by the animals.
Psf-based implants with different surface charcateristics were
evaluated for their in vivo biocompatibility in rat model. These
implants exhibited improved biocompatibility over commercially
available membranes. The post-implantation CBC, renal and
liver function tests indicated normal health of rat signifying
absence of infections due to surgical procedures. Peritoneal fluid
cytology exhibited elevated PMNs at day 7 post-implantation due
to initial inflammation which returned within the normal range
by day 21 indicating absence of chronic inflammation. Histopa-
thology studies revealed abundunt fibroblast and angiogenesis in
the tissues surrounding Psf/TPGS implants as compared to Psf,
Psf/MPC and Hemoflow F6 implants indicating imporved
biocompatiblity of Psf/TPGS implants attributable to the cleaved
Vitamin E moiety. Immune responses against all the implants
were absent. This study may be useful for generation of hollow
fiber based vascular grafts which are able to grow within the
peritoneal cavity.
Materials and Methods
Ethics Statement
All the animal experimental protocols were approved by
Committee for the Purpose of Control and Supervision of
Experiments on Animals (CPCSEA), India and animal ethical
committee of Mumbai Veterinary College (MVC), Mumbai.
Preparation of Hollow Fiber membrane
Psf (UDELTM P-3500 LCD MB7-BULK) was procured from
M/s. Solvay Advanced Polymers, USA and dried in vacuum oven
Table 3. Inflammatory evaluation of intraperitoneal HFMs implants.
Implantation
Period (days) Implant Type PMC Macrophages Lymphocytes Fibroblast Angiogenesis Collagen Bundles
7P s f + + +++ + +Thin
21 Psf + +++ + + +Thick
7 Psf/TPGS + +++ + + +Thin
21 Psf/TPGS + ++ + +++ ++ Thick
7 Psf/MPC + + ++ ++ ++ Thin
21 Psf/MPC + ++ + +++ ++ Thick
7 Hemoflow F6 ++ + ++ + + Thin
21 Hemoflow F6 ++ + + + + + + Thick
doi:10.1371/journal.pone.0025236.t003
Figure 2. Tissue-HFM interaction study by Scanning Electron Microscopy. SEM micrographs of HFMs implants at day 21 (a) Psf (b) Psf/TPGS
(c) MPC coated Psf and (d) Hemoflow F6 showing integration developed tissue with HFMs implants [scale bar: (a) 500 mm and (b), (c), (d) 1 mm (inset:
(a), (b), (c) and (d) 100 mm)].
doi:10.1371/journal.pone.0025236.g002
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stained tissue section of normal rat peritoneum at day 7 (a) and day 21 (b); Psf HFMs implants at day 7 (c) and day (d); Psf/TPGS HFMs implants at day
7 (e) and day 21 (f); Psf/MPC HFMs implants at day 7 (g) and day 21(h); Hemoflow F6 HFMs implants at day 7 (i) and day 21 (j). Arrow head, cross and
big white arrow denotes fibroblast, angiogenesis and interface of implant with tissue respectively. [Scale bar: 100 mm (inset: 20 mm)]. Note: Psf/TPGS
(e and f) and Psf/MPC (g and h) implants were detached during tissue processing for histology, but tissue interface with implants are distinctly visible.
doi:10.1371/journal.pone.0025236.g003
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PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e25236Figure 4. Histopathological analysis of implant by Masson’s trichrome stain. Optical photomicrograph of Masson’s trichrome stained tissue
section of normal normal rat peritoneum at day 7 (a) and day 21 (b); Psf HFMs implants at day 7 (c) and day 21 (d); Psf/TPGS HFMs implants at day 7
(e) and day 21 (f); Psf/MPC HFMs implants at day 7 (g) and day 21 (h); Hemoflow F6 HFMs implants at day 7 (i) and day 21 (j). The symbols t and T
denotes thin, thick blue collagen bundles respectively, while arrow shows interface implant with tissue. [Scale bar: 100 mm (inset: 20 mm)]. Note:
Some hollow fiber implants are detached (c, d, e, f, and g) during processing for histology.
doi:10.1371/journal.pone.0025236.g004
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grade) and MPC polymers PC 2118 [Poly(2-methacryloylox-
yethyl)-29-(trimethylammoniumethyl) phosphate, inner salt)-co-(3-
(trimethoxysilyl)propyl methacrylate)-co-(hydroxypropyl methac-
rylate)] were generously gifted by M/s. Isochem SA (Paris, France)
and M/s. Vertellus Specialties Inc., (Basinstoke, UK), respectively.
The solvent, N-methyl2-pyrrolidone (NMP), was procured from
S.D. Fine-Chem Ltd., India. Psf and Psf/TPGS composite HFMs
were prepared as per the conditions and compositions listed in
Table 4. The prepared fibers were kept in water for one day to
remove the residual solvent and then used for further studies.
Implantation of HFM into Peritoneal Cavity
Wistar female rats (age group of 4–5 weeks) were procured from
Bombay Veterinary College animal house and were housed under
controlled conditions of light (12 h light and 12 h darkness),
temperature (24uC) and humidity (50%) and maintained on
normal chow and water.
Recipient rats were anesthetized (ketamine-80 mg/kg and
xylazine-8 mg/kg, i.p.), shaved, and cleaned and were subjected
to a laparotomy through a 1 cm long incision on the lower right
abdominal wall. The exposed area was kept moist with normal
saline swab. A bunch of three HFMs (each 1.5 cm long) was slowly
delivered inside the peritoneal cavity. Finally, the peritoneum and
skin were sutured using absorbable 6–0 catgut sutures (Stericat
Gutstrings, Delhi). Approximately 2 mm part of the HFMs was
kept above the peritoneum while suturing to avoid implant
dislocation.
The study consisted of 6 groups (n=3) corresponding to Psf,
Psf/TPGS, Psf/MPC HFMs and commercial membranes (Hemo-
flow F6, Fresenius Medical Care), normal (no surgery) and sham
(surgery without implant). Samples were assessed on day 7 and day
21. All rats (control and experimental) received an i.p. injection of
gentamycin (3 mg/kg body weight), ampicillin and cloxacillin
(20 mg/kg body weight) and diclofenac sodium (0.5 mg/kg body
weight) for 3 days (starting from the day of operation) in addition
to the topical ointments (SoframycinH, Aventis Pharma. Ltd.,
Pune, India) and placed in a cage on a heating pad.
Figure 5. Immunohistochemistry of implants. Confocal laser
micrographs of immunohistochemical stained tissue of (a) Psf HFMs, (b)
Psf/TPGS HFMs, (c) Psf/MPC HFMs and (d) Hemoflow F6 HFMs implants
with DAPI for nuclei (blue) [scale: 100 mm].
doi:10.1371/journal.pone.0025236.g005
Table 4. Process parameters used for hollow fiber membrane preparation.
Parameters Psf HFMs Psf/TPGS HFMs MPC coated Psf HFMs (Psf/MPC)
Ambient Temperature (uC) 25 25 25
Relative Humidity (%) 50–60 50–60 50–60
Dope Solution Composition Psf/NMP (25/75) Psf/TPGS/NMP (25/20/55) Psf/NMP (25/75)
Bore Solution Composition DI Water DI Water 10 mg/ml PC 2118 in DI water
Dope Solution Temperature (uC) 25 25 25
Bore Solution Temperature (uC) 25 25 25
Dope Flow Rate (ml/min) 2 2 2
Bore Flow Rate (ml/min) 2.5 2.5 2.5
Spinneret ID/OD (mm) 0.8/1.4 0.8/1.4 0.8/1.4
Air Gap (cm) 45 45 45
Coagulation Bath Composition RO Water RO Water RO Water
Rinse Bath Composition RO Water RO Water RO Water
Coagulation Bath Temperature (uC) 25 25 25
Rinse Bath Temperature (uC) 35 35 35
Take-up Drum Velocity (m/min) 3.89 3.01 3.89
doi:10.1371/journal.pone.0025236.t004
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A complete blood count was performed for diagnosis of
infections and inflammatory responses. Retro-orbital blood
collection was performed in two vials (with and without heparin,
1 ml each) as described by Sorg and Buckner [16] on days 7 and
21. The heparin (2 IU/ml) containing vial was used for
hematological studies, while second vial without heparin was used
for serum biochemistry study. Complete Blood Count (CBC) was
performed using Abacus (Diatron MI PLC, Hungary) hematology
analyzer, while serum biochemistry evaluation was done on Erba
Chem 7 (Erba Mannheim, Germany) semi-autoanalyzer using
commercial reagent kits.
Peritoneal Fluid Cytology
Peritoneal fluid cytology was carried out for evaluating
inflammatory responses due to implantation. On days 7 and 21,
three rats from each group were scarified by euthanizing in a CO2
chamber and their abdominal cavities were exposed. The cavities
were filled with 5 ml of chilled phosphate buffer saline (PBS) and
were massaged gently for 3–5 min. The PBS solution was
aspirated; cytospinned and stained using Wright-Giemsa stain
(Sigma Aldrich, MO, USA). The slides were then air-dried and a
leukocyte differential count was performed by counting the cells in
a standard clinical hemocytometer.
Histological Study of Implants
Histopathological evaluation was carried out on days 7 and 21
for sacrificed rats from all the different groups. HFM implants
along with the surrounding tissue were excised and fixed with 10%
formalin, embedded in paraffin, sectioned (2–3 mm thick) with a
microtome at three different distances from the surface, and
stained with hematoxylin and eosin (H&E) (Sigma Aldrich, MO,
USA) as per standard protocol [17]. Sections were then examined
for the presence of fibrin, exudates, induction of vascularization,
and formation of fibrous capsule. Sections were also stained with
Masson’s Trichrome and observed for extent and distribution of
collagen fibers in tissue [18].
Scanning electron microscopy (SEM) Study
Fixed HFM implants with tissue were sectioned with a sharp
cutter, dehydrated with graded alcohol and dried at room
temperature. These samples were coated with gold/palladium
using SC7640 Sputter Coater (Quorum Technologies Ltd, UK)
and observed under scanning electron microscope (Hitachi, S-
3400 N, UK).
Immunohistochemistry Study
Implant sections were prepared as described above. Paraffin was
removed using xylene and the sections were hydrated using a series
of washes in graded alcohol. The sections were then washed with
PBS and heated in 10 mM sodium citrate using microwave oven
for antigen retrieval. They were fixed with 4% paraformaldehyde
for 20 min, washed with PBS and permeabilized using 0.1%
triton-x solution [19]. This was followed by exposure to
phycoerythrin (PE) conjugated HLA- DR antibody (Santa Cruz
Biotechnology, Inc., CA, USA) (1:200) for 1 h in dark at room
temperature to stain major histocompatibility complex (MHC)
antigens. Finally, sections on glass slides were mounted using an
antifade-containing mounting medium (Vectashield, Vector labo-
ratories, Burlingame, USA) and 49,6-diamidoino-2-phenylindole
(DAPI) (Sigma-Aldrich, USA). Images were captured using a
Zeiss-LSM 510 laser scanning confocal microscope (Carl Zeiss
Meditec AG, Jena, Germany) using 106objectives.
Supporting Information
Data S1 Hematology and serum biochemistry of blood
collected on day 7 & 21.
(DOC)
Acknowledgments
The authors would like to acknowledge Ms. Ashwini Atre (National Center
for Cell Science, Pune) for image acquiring on confocal laser scanning
microscopy.
Author Contributions
Conceived and designed the experiments: GD SK. Performed the
experiments: GD SK SS. Analyzed the data: GD SK SS DK. Contributed
reagents/materials/analysis tools: JB. Wrote the paper: GD SK.
Scientifically contributed and reviewed the article: LS JB.
References
1. Clark WR, Gao D, Ronco C (2002) Membranes for Dialysis. In: Hemodialysis
Technology. pp 70–77.
2. Cheung AK (1990) Biocompatibility of hemodialysis membranes. Journal of the
American Society of Nephrology 1: 150–161.
3. Hakim RM (1993) Clinical implications of hemodialysis membrane biocompat-
ibility. Kidney International 44: 484–494.
4. Janvier G, Baquey C, Roth C, Benillan N, Belisle S, et al. (1996) Extracorporeal
Circulation, Hemocompatibility, and Biomaterials. Ann Thorac Surg 62:
1926–1934.
5. Sirolli V, Ballone E, Di Stante S, Amoroso L, Bonomini M (2002) Cell activation
and cellular-cellular interactions during hemodialysis: Effect of dialyzer
membrane. International Journal of Artificial Organs 25: 529–537.
6. Schiffl H, Lang SM, Ko ¨nig A, Strasser T, Haider M, et al. (1994) Biocompatible
membranes in acute renal failure: prospective case-controlled study. The Lancet
344: 570–572. doi: DOI: 10.1016/S0140-6736(94)91964-X.
7. Subramanian S, Venkataraman R, Kellum JA (2002) Influence of dialysis
membranes on outcomes in acute renal failure: A meta-analysis. Kidney Int 62:
1819–1823.
8. Williams DF (1999) The Williams dictionary of biomaterials. In:Liverpool
University Press, Liverpool, UK. 40 p.
9. Ishihara K, Fukumoto K, Miyazaki H, Nakabayashi N (1994) Improvement of
hemocompatibility on a cellulose dialysis membrane with a novel biomedical
polymer having a phospholipid polar group. Artificial Organs 18: 559–564.
10. Lin WC, Liu TY, Yang MC (2004) Hemocompatibility of polyacrylonitrile
dialysis membrane immobilized with chitosan and heparin conjugate. Bioma-
terials 25: 1947–1957. doi: DOI: 10.1016/j.biomaterials.2003.08.027.
11. Dahe GJ, Teotia RS, Kadam SS, Bellare JR (2011) The biocompatibility and
separation performance of antioxidative polysulfone/vitamin E TPGS compos-
ite hollow fiber membranes. Biomaterials 32: 352–365. doi: DOI: 10.1016/
j.biomaterials.2010.09.005.
12. Pastan S, Bailey J (1998) Medical progress: Dialysis therapy. New England
Journal of Medicine 338: 1428–1437.
13. [Anonymous] (2003) ISO 10993-1:2003, Biological evaluation of medical
devices Part 1: Evaluation and testing. pp 1–24.
14. [Anonymous] (1999) ISO 10993-5:1999, Biological evaluation of medical
devices Part 5: Tests for in vitro cytotoxicity. pp 1–24.
15. Keller JC, Marshall GW, Kaminski EJ (1984) An in vivo method for the
biological evaluation of metal implants. J Biomed Mater Res 18: 829–844.
10.1002/jbm.820180713.
16. Sorg D, Buckner D (1964) A simple method of obtaining venous blood from
small laboratory animals. Proceedings of the Society for Experimental Biology
and Medicine 115: 1131–1132.
17. Luna GL (1968) Manual of histologic staining methods of the Armed Forces
Institute of Pathology. In:McGraw-Hill Book Company, New York. pp 82–83.
18. Sheehan D, Hrapchak B (1980) Theory and practice of Histotechnology.
In:Battelle Press, Ohio. pp 189–190.
19. Shi SR, Key ME, Karla KL (1991) Antigen retrieval in formalin-fixed, paraffin-
embedded tissues: an enhancement method for immunohistochemical staining based
on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741–748.
20. Bolliger AP, Everds NE, Zimmerman KL, Moore DM, Smith SA, et al. (2010)
Hematology of Laboratory Animals. In: Weiss DJ, Wardrop KJ, eds. Schalm’s
Veterinary Hematology. pp 852–862.
In Vivo Biocompatibility of Psf Hollow Fibers
PLoS ONE | www.plosone.org 8 October 2011 | Volume 6 | Issue 10 | e2523621. Andorson JM (2004) Inflammation, wound healing and the foreign body
response. Biomaterials Science: An Introduction to Materials in Medicine. pp
296–304.
22. Alpaslan G, Nakajima T, Takano Y (1997) Extracellular alkaline phosphatase
activity as a possible marker for wound healing: a preliminary report. J Oral
Maxillofac Surg 55: 56–62. S0278-2391(97)90447-X [pii].
23. Liu Y, Zheng S, X, Prestwich GD (2005) Biocompatibility and stability of
disulfide-crosslinked hyaluronan films. Biomaterials 26: 4737–4746. S0142-
9612(05)00004-9 [pii]; 10.1016/j.biomaterials.2005.01.003 [doi].
24. Jeong SI, Kim BS, Kang SW, Kwon JH, Lee YM, et al. (2004) In vivo
biocompatibilty and degradation behavior of elastic poly(L-lactide-co-epsilon-
caprolactone) scaffolds. Biomaterials 25: 5939–5946. 10.1016/j.biomateri-
als.2004.01.057 [doi]; S0142961204001127 [pii].
25. Traber MG, Thellman CA, Rindler MJ, Kayden HJ (1988) Uptake of intact
TPGS (d-alpha-tocopheryl polyethylene glycol 1000 succinate) a water-miscible
form of vitamin E by human cells in vitro. Am J Clin Nutr 48: 605–611.
26. Yan A, Von Dem BA, Kane AB, Hurt RH (2007) Tocopheryl Polyethylene
Glycol Succinate as a Safe, Antioxidant Surfactant for Processing Carbon
Nanotubes and Fullerenes. Carbon N Y 45: 2463–2470. 10.1016/j.carbon.
2007.08.035 [doi].
27. Oczenski W, Krenn H, Jilch R, Watzka H, Waldenberger F, et al. (2003) HLA-
DR as a marker for increased risk for systemic inflammation and septic
complications after cardiac surgery. Intensive Care Med 29: 1253–1257.
10.1007/s00134-003-1826-8 [doi].
28. Voggenreiter G, Leiting S, Brauer H, Leiting P, Majetschak M, et al. (2003)
Immuno-inflammatory tissue reaction to stainless-steel and titanium plates used for
internal fixation of long bones. Biomaterials 24: 247–254. S0142961202003125 [pii].
In Vivo Biocompatibility of Psf Hollow Fibers
PLoS ONE | www.plosone.org 9 October 2011 | Volume 6 | Issue 10 | e25236